爱美客：子公司取得米诺地尔搽剂《药品注册证书》

Core Viewpoint - Aimer (300896.SZ) announced that its wholly-owned subsidiary, Beijing Nobot Biotechnology Co., Ltd., has received approval from the National Medical Products Administration for the registration of Minoxidil topical solution in 2% and 5% concentrations, which are non-prescription dermatological medications [1] Group 1 - The 2% formulation is indicated for the treatment of androgenetic alopecia and alopecia areata [1] - The 5% formulation is restricted for use by males only, also for the treatment of androgenetic alopecia and alopecia areata [1] - Minoxidil is a peripheral vasodilator that, when used topically over a long period, can stimulate hair growth in male patients suffering from androgenetic alopecia and alopecia areata [1]